152 related articles for article (PubMed ID: 38301662)
1. Corrigendum to: Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism.
Cardiovasc Res; 2024 Jul; 120(8):971. PubMed ID: 38301662
[No Abstract] [Full Text] [Related]
2. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism.
Cao D; Khan Z; Li X; Saito S; Bernstein EA; Victor AR; Ahmed F; Hoshi AO; Veiras LC; Shibata T; Che M; Cai L; Temel RE; Giani JF; Luthringer DJ; Divakaruni AS; Okwan-Duodu D; Bernstein KE
Cardiovasc Res; 2023 Aug; 119(9):1825-1841. PubMed ID: 37225143
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
Chinetti G; Fruchart JC; Staels B
Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model.
Rivier M; Castiel I; Safonova I; Ailhaud G; Michel S
J Invest Dermatol; 2000 Apr; 114(4):681-7. PubMed ID: 10733673
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
6. Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
Tordjman KM; Semenkovich CF; Coleman T; Yudovich R; Bak S; Osher E; Vechoropoulos M; Stern N
Hypertension; 2007 Nov; 50(5):945-51. PubMed ID: 17909121
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and Atherosclerosis.
Yu XH; Zheng XL; Tang CK
Adv Clin Chem; 2015; 71():171-203. PubMed ID: 26411415
[TBL] [Abstract][Full Text] [Related]
8. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression.
Sartippour MR; Renier G
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):104-10. PubMed ID: 10634806
[TBL] [Abstract][Full Text] [Related]
10. The role of peroxisome proliferator-activated receptor γ in lipid metabolism and inflammation in atherosclerosis.
Yang XF; Shang DJ
Cell Biol Int; 2023 Sep; 47(9):1469-1487. PubMed ID: 37369936
[TBL] [Abstract][Full Text] [Related]
11. Classical and nonclassical effects of angiotensin-converting enzyme: How increased ACE enhances myeloid immune function.
Bernstein KE; Cao D; Shibata T; Saito S; Bernstein EA; Nishi E; Yamashita M; Tourtellotte WG; Zhao TV; Khan Z
J Biol Chem; 2024 Jun; 300(6):107388. PubMed ID: 38763333
[TBL] [Abstract][Full Text] [Related]
12. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
13. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
[TBL] [Abstract][Full Text] [Related]
14. The possible therapeutic actions of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, PPAR gamma agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial cells.
Inoue I; Katayama S
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):35-52. PubMed ID: 15032651
[TBL] [Abstract][Full Text] [Related]
15. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
16. Triterpenoids from Hibiscus sabdariffa L. with PPARδ/γ Dual Agonist Action: In Vivo, In Vitro and In Silico Studies.
Giacoman-Martínez A; Alarcón-Aguilar FJ; Zamilpa A; Hidalgo-Figueroa S; Navarrete-Vázquez G; García-Macedo R; Román-Ramos R; Almanza-Pérez JC
Planta Med; 2019 Mar; 85(5):412-423. PubMed ID: 30650453
[No Abstract] [Full Text] [Related]
17. Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II.
Garnier A; Zoll J; Fortin D; N'Guessan B; Lefebvre F; Geny B; Mettauer B; Veksler V; Ventura-Clapier R
Circ Heart Fail; 2009 Jul; 2(4):342-50. PubMed ID: 19808358
[TBL] [Abstract][Full Text] [Related]
18. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.
Molaei A; Molaei E; Hayes AW; Karimi G
Cell Cycle; 2023 Jul; 22(13):1654-1674. PubMed ID: 37365840
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor A/G reprogrammes metabolism associated with lipid accumulation in macrophages.
Ye G; Gao H; Lin Y; Ding D; Liao X; Zhang H; Chi Y; Dong S
Metabolomics; 2019 Mar; 15(3):36. PubMed ID: 30830452
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha is essential factor in enhanced macrophage immune function induced by angiotensin converting enzyme.
Saito S; Cao D; Bernstein EA; Jones AE; Rios A; Hoshi AO; Stotland AB; Nishi EE; Shibata T; Ahmed F; Van Eyk JE; Divakaruni A; Khan Z; Bernstein KE
Res Sq; 2024 Apr; ():. PubMed ID: 38746124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
